Kiniksa Pharmaceuticals International, plc (KNSA): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

78.98M
Year ended 2025-12-31
+3.9%
3-year compound annual growth
+5.0%
5-year compound annual growth
2019-12-31: 54.05M2020-12-31: 61.84M2021-12-31: 68.58M2022-12-31: 70.42M2023-12-31: 71.92M2024-12-31: 71.42M2025-12-31: 78.98M78.98M
2019-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-3178.98M+10.6%2026-02-24, From 2025-01-01
2024-12-3171.42M-0.7%2026-02-24, From 2024-01-01
2023-12-3171.92M+2.1%2026-02-24, From 2023-01-01
2022-12-3170.42M+2.7%2025-02-25, From 2022-01-01
2021-12-3168.58M+10.9%2024-02-28, From 2021-01-01
2020-12-3161.84M+14.4%2023-03-02, From 2020-01-01
2019-12-3154.05Mn/a2022-02-24, From 2019-01-01